Visualization of chikungunya virus infection in vitro and in vivo

被引:13
|
作者
Zhang, Hong-Lei [1 ,2 ]
Dong, Hao-Long [3 ]
Zhang, Ya-Nan [1 ]
Xu, Lin-Lin [1 ]
Deng, Cheng-Lin [1 ]
Li, Xiao-Feng [3 ,4 ]
Li, Xiao-Dan [5 ]
Ye, Han-Qing [1 ]
Yuan, Zhi-Ming [1 ]
Qin, Cheng-Feng [3 ,4 ]
Zhang, Bo [1 ,6 ]
机构
[1] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China
[2] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China
[3] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
[4] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China
[5] Hunan Normal Univ, Sch Med, Changsha, Hunan, Peoples R China
[6] Nankai Univ, Drug Discovery Ctr Infect Dis, Tianjin 300350, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Chikungunya virus; iRFP; reporter virus; live imaging; mice; DENGUE VIRUS; REPLICATION; INTERFERON; PATHOGENESIS; MICE;
D O I
10.1080/22221751.2019.1682948
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chikungunya virus (CHIKV), a mosquito-borne alphavirus, has become an important re-emerging pathogen with its rapid spread to many non-endemic areas. The lack of effective vaccines and antiviral agents is largely attributed to the elusive infection and dissemination dynamics in vivo. In this study, we designed and developed a novel, replication-competent, CHIKV reporter virus (CHIKV-iRFP) encoding a near infrared fluorescent protein (iRFP). In vitro and in vivo characterization demonstrated that CHIKV-iRFP retained similar replication and virulence phenotypes to its parental virus. Neonatal BABL/c mice and IFNAR(?/?) A129 mice were highly susceptible to CHIKV-iRFP infection. Following intracranial (i.c.) inoculation, CHIKV-iRFP efficiently replicated and disseminated into whole body, resulting in rapid death in an age-dependent manner. Remarkably, upon footpad injection, CHIKV-iRFP readily disseminated from footpad to head and whole skeleton, with a specific tropism for bone marrow. Taken together, this novel reporter virus provides a powerful tool to track real time CHIKV replication and to test the in vivo efficacy of vaccines and antiviral therapeutics.
引用
收藏
页码:1574 / 1583
页数:10
相关论文
共 50 条
  • [1] Telmisartan Restricts Chikungunya Virus Infection In Vitro and In Vivo through the AT1/PPAR-γ/MAPKs Pathways
    De, Saikat
    Mamidi, Prabhudutta
    Ghosh, Soumyajit
    Keshry, Supriya Suman
    Mahish, Chandan
    Pani, Sweta Smita
    Laha, Eshna
    Ray, Amrita
    Datey, Ankita
    Chatterjee, Sanchari
    Singh, Sharad
    Mukherjee, Tathagata
    Khamaru, Somlata
    Chattopadhyay, Subhasis
    Subudhi, Bharat Bhusan
    Chattopadhyay, Soma
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (01)
  • [2] Interferon-induced restriction of Chikungunya virus infection
    Suzuki, Youichi
    ANTIVIRAL RESEARCH, 2023, 210
  • [3] Recent developments and challenges in mouse models of Chikungunya virus infection
    Yeo, Li Sze
    Chu, Justin Jang Hann
    FUTURE VIROLOGY, 2013, 8 (05) : 423 - 426
  • [4] Chikungunya virus infection in BALB/c and ICR mouse models
    Tiawsirisup, Sonthaya
    Tuanudom, Ranida
    Yurayart, Nichapat
    THAI JOURNAL OF VETERINARY MEDICINE, 2016, 46 (04): : 705 - 712
  • [5] Nifuroxazide Prevents Chikungunya Virus Infection Both In Vitro and In Vivo via Suppressing Viral Replication
    Liu, Yangang
    Xu, Mingxiao
    Xia, Binghui
    Qiao, Zhuoyue
    He, Yanhua
    Liu, Yan
    Pan, Zhendong
    Zhang, Congcong
    Peng, Haoran
    Liang, Xuesong
    Zhao, Ping
    Tang, Hailin
    Zheng, Xu
    VIRUSES-BASEL, 2024, 16 (08):
  • [6] Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression
    Neupane, Biswas
    Acharya, Dhiraj
    Nazneen, Farzana
    Gonzalez-Fernandez, Gabriel
    Flynt, Alex Sutton
    Bai, Fengwei
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [7] Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication
    Zheng, Xu
    He, Yanhua
    Xia, Binghui
    Tang, Wanda
    Zhang, Congcong
    Wang, Dawei
    Tang, Hailin
    Zhao, Ping
    Peng, Haoran
    Liu, Yangang
    PHARMACEUTICS, 2024, 16 (09)
  • [8] Control of immunopathology during chikungunya virus infection
    Petitdemange, Caroline
    Wauquier, Nadia
    Vieillard, Vincent
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (04) : 846 - 855
  • [9] Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo
    Rothan, Hussin A.
    Bahrani, Hirbod
    Abdulrahman, Ammar Y.
    Mohamed, Zulqarnain
    Teoh, Teow Chong
    Othman, Shatrah
    Rashid, Nurshamimi Nor
    Rahman, Noorsaadah A.
    Yusof, Rohana
    ANTIVIRAL RESEARCH, 2016, 127 : 50 - 56
  • [10] In vivo infection by a neuroinvasive neurovirulent dengue virus
    Velandia-Romero, Myriam Lucia
    Acosta-Losada, Orlando
    Castellanos, Jaime E.
    JOURNAL OF NEUROVIROLOGY, 2012, 18 (05) : 374 - 387